209325-64-4Relevant articles and documents
Mesomorphic phase transition behavior of novel triphenylene compounds possessing fluoroalkylated side chains
Terasawa, Naohiro,Monobe, Hirosato,Kiyohara, Kenji
, p. 954 - 961 (2006)
This report discusses the effect of fluoroalkyl chain on the mesomorphism. Several homologues of novel triphenylene compounds possessing fluoroalkylated side chains were synthesized. Studies of X-ray diffraction, DSC and texture observations by polarized
Tamoxifen and fulvestrant hybrids showed potency as selective estrogen receptor down-regulators
Shoda, Takuji,Kato, Masashi,Fujisato, Takuma,Demizu, Yosuke,Inoue, Hideshi,Naito, Mikihiko,Kurihara, Masaaki
, p. 206 - 213 (2017/02/05)
Background: Estrogen receptors (ERs) are an important target for the management of breast cancers. Selective estrogen receptor down-regulators (SERDs) block ER activity, as well as reduce ERα protein levels in cells, and therefore are promising therapeuti
6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS
-
Paragraph 0393; 0394; 0395; 0396, (2013/10/07)
The invention relates to selective oestrogen receptor modulators (SERM) and methods of production thereof, use thereof for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or proph